Please Wait
Applying Filters...
menu
    • menu
    Strides Pharma Science-PSE
    News
    India Advances Epilepsy Treatment with New Drugs & Surgical Options

    16 Nov 2024

    // PHARMABIZ

    Strides Pharma Reports Q2 FY25 Consolidated PAT of Rs. 93.23 Cr

    28 Oct 2024

    // #N/A

    Strides Pharma reports Q2 FY25 consolidated PAT at Rs. 93.23 Cr

    24 Oct 2024

    // PRESS RELEASE

    Data Compilation
    #PharmaFlow

    Strides Pharma Science

    Contact Supplier

    Website

    CPhI India 2024

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments
    Menu

    Strides Pharma Science

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2024

    read-more

      https://www.pharmacompass.com/pdf/party/content/strides-pharma-science-party-content-34447.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/strides-pharma-science-party-content-3803.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Manufacturing Sites and R&D Center

    read-more

      https://www.pharmacompass.com/pdf/party/content/strides-pharma-science-party-content-28236.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    GMP Certificate 2021

    read-more

      https://www.pharmacompass.com/pdf/party/content/strides-pharma-science-party-content-60913.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    India Advances Epilepsy Treatment with New Drugs & Surgical Options
    India Advances Epilepsy Treatment with New Drugs & Surgical Options

    16 Nov 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=173589&sid=1

    PHARMABIZ
    16 Nov 2024
    Share Share
    Strides Pharma Reports Q2 FY25 Consolidated PAT of Rs. 93.23 Cr
    Strides Pharma Reports Q2 FY25 Consolidated PAT of Rs. 93.23 Cr

    28 Oct 2024

    // #N/A

    https://strides.com/pdf/pressrelease/2024/SEIntimationResults_24_oct_2024.pdf

    #N/A
    28 Oct 2024
    Share Share
    Strides Pharma reports Q2 FY25 consolidated PAT at Rs. 93.23 Cr
    Strides Pharma reports Q2 FY25 consolidated PAT at Rs. 93.23 Cr

    24 Oct 2024

    // PRESS RELEASE

    https://strides.com/pdf/pressrelease/2024/SEIntimationResults_24_oct_2024.pdf

    PRESS RELEASE
    24 Oct 2024
    Share Share
    OneSource receives equity of Rs 8,010 Mn at a pre-money equity
    OneSource receives equity of Rs 8,010 Mn at a pre-money equity

    18 Oct 2024

    // PRESS RELEASE

    https://strides.com/pdf/pressrelease/2024/StridesSEIntimation_16_Oct_2024.pdf

    PRESS RELEASE
    18 Oct 2024
    Share Share
    OneSource unveils new brand identity at CPHI Milan
    OneSource unveils new brand identity at CPHI Milan

    10 Oct 2024

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/onesource-unveils-new-brand-identity-at-cphi-milan-16309

    INDPHARMAPOST
    10 Oct 2024
    Share Share
    OneSource in talks to raise Rs 1,670 crore in pre-listing round
    OneSource in talks to raise Rs 1,670 crore in pre-listing round

    26 Sep 2024

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/onesource-in-talks-to-raise-rs-1670-crore-in-pre-listing-round/articleshow/113677721.cms

    ECONOMICTIMES
    26 Sep 2024
    Share Share